Ignite Creation Date:
2025-12-24 @ 7:17 PM
Ignite Modification Date:
2026-02-19 @ 5:57 AM
Study NCT ID:
NCT04268303
Status:
COMPLETED
Last Update Posted:
2023-06-18
First Post:
2020-02-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
Sponsor:
BioXcel Therapeutics Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BXCL501-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |